The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Interstitial lung disease in polymyositis and dermatomyositis
Abstract
Objectives: To assess prevalence, characteristics, and long‐term outcome of interstitial lung disease (ILD) in polymyositis (PM) and dermatomyositis (DM). To determine predictive variables of ILD course in PM/DM, and to define both clinical and biochemical features associated with ILD onset in PM/DM. Methods: The medical records of 156 consecutive PM/DM patients in 3 medical centers were reviewed. Results: Thirty‐six PM/DM patients (23.1%) developed ILD. We observed that 19.4% of patients with ILD had resolution of pulmonary disorders, whereas 25% experienced ILD deterioration. Morbidity and mortality rates were as high as 13.9% and 36.4%, respectively, in PM/DM patients with ILD. Parameters of PM/DM that related to ILD poor outcome were identified as follows: Hamman‐Rich–like pattern, initial diffusing capacity of carbon monoxide <45%, neutrophil alveolitis, and histologic usual interstitial pneumonia. Additionally, for the group with ILD, polyarthritis, higher values of erythrocyte sedimentation rate and C‐reactive protein, presence of anti–Jo‐1 antibody, and characteristic microangiopathy were significantly more frequent. Conclusion: Our series underlines the high frequency of ILD in PM/DM patients, resulting in increased morbidity and mortality rates. It also indicates that PM/DM patients should routinely be screened for ILD, even those patients without anti–Jo‐1 antibody, because 69% of our ILD patients were seronegative for the anti–Jo‐1 antibody. Our findings further suggest that PM/DM patients presenting with factors predictive of ILD poor outcome may require more aggressive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Polymyositis and Dermatomyositis: (Second of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920807 · Cited by 2,447
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Love, L. A., Leff, R. L., Fraser, D. D., Targoff, I. N., Dalakas, M., Plotz, P. H., & Miller, F. W. (1991) · Medicine · doi:10.1097/00005792-199111000-00002 · Cited by 969
Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance
Katzenstein, A.-L. A., & Fiorelli, R. F. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199402000-00003 · Cited by 755
Polymyositis–Dermatomyositis-associated Interstitial Lung Disease
DOUGLAS, W. W., TAZELAAR, H. D., HARTMAN, T. E., HARTMAN, R. P., DECKER, P. A., SCHROEDER, D. R., & RYU, J. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2103110 · Cited by 557
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
DANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase Enzymes
Marguerie, C., Bunn, C. C., Beynon, H. L. C., Bernstein, R. M., Hughes, J. M. B., So, A. K., & Walport, M. J. (1990) · QJM · doi:10.1093/qjmed/77.1.1019 · Cited by 372
Tazelaar, H. D., Viggiano, R. W., Pickersgill, J., & Colby, T. V. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.727 · Cited by 357
Cited by
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies
Connors, G. R., Christopher-Stine, L., Oddis, C. V., & Danoff, S. K. (2010) · Chest · doi:10.1378/chest.10-0180 · Cited by 564
Cryptogenic organising pneumonia
Cordier, J.-F. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00013505 · Cited by 519
Gerami, P., Schope, J. M., McDonald, L., Walling, H. W., & Sontheimer, R. D. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.041 · Cited by 455
Pulmonary Manifestations of Primary Sjögren's Syndrome: A Clinical, Radiologic, and Pathologic Study
Ito, I., Nagai, S., Kitaichi, M., Nicholson, A. G., Johkoh, T., Noma, S., Kim, D. S., Handa, T., Izumi, T., & Mishima, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-417oc · Cited by 358
Metadata
- Authors
- Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P. ‐., Hellot, M. ‐., Devulder, B., Herson, S., Levesque, H., & Courtois, H.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2002-12-12
- Volume
- 47
- Issue
- 6
- Pages
- 614-622
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1974113719
- Cited by
- 478
- References
- 20
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interstitial lung disease in polymyositis and dermatomyositis. https://app.cochat.ai/papers/10.1002/art.10794
- The paper
- Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P. ‐., Hellot, M. ‐., Devulder, B., Herson, S., Levesque, H., & Courtois, H. (2002). Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Care & Research. https://doi.org/10.1002/art.10794
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.